Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,617 across all filing types
Latest filing 2023-05-12 Regulatory Filings
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
112年第1季大陸投資
Regulatory Filings Classification · 95% confidence The document is a tabular disclosure of investment amounts and related financial data concerning the company's investments in mainland China. It includes details such as capital amounts, investment methods, cumulative investment amounts, and investment income recognized. The document is relatively short (1302 characters) and appears to be a regulatory disclosure of investment information rather than a full financial report or announcement. There is no indication that this is an annual or interim report, audit report, or earnings release. It also does not fit into categories like management changes, voting results, or capital changes. Given the nature of the data and the context, this document is best classified as a Regulatory Filing (RNS), which serves as a fallback for miscellaneous regulatory disclosures that do not fit other categories.
2023-05-12 Chinese
112年第1季權益變動表
Interim / Quarterly Report Classification · 90% confidence The document contains detailed financial data specifically about changes in consolidated equity for a company, including line items such as common stock, capital surplus, legal surplus reserve, special surplus reserve, undistributed earnings, retained earnings, foreign currency translation adjustments, and total equity attributable to the parent company and non-controlling interests. The data is presented for the current period (Q1 2023) and the same period last year (Q1 2022). The presence of detailed financial tables with actual figures and accounting items indicates this is a substantive financial report rather than a brief announcement or certification. The document length is 2974 characters, which is relatively short but contains actual financial data. Given the quarterly period and the detailed financial data, this fits the definition of an Interim / Quarterly Report (IR). Q1 2023
2023-05-11 Chinese
112年第1季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the first quarter of the fiscal year 112 (which corresponds to 2023 in the Gregorian calendar). It includes detailed financial data such as cash flows from operating, investing, and financing activities, with specific amounts and accounting items. The presence of actual financial statements for a quarterly period indicates this is a comprehensive interim or quarterly financial report. The document length is 1936 characters, which is relatively short but contains substantive financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2023
2023-05-11 Chinese
112年第1季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement for the first quarter of the year 112 (which corresponds to 2023 in the Taiwanese calendar). It includes detailed financial data such as revenue, costs, expenses, net income, and earnings per share for the quarter ending March 31, 2023, compared to the same period in the previous year. The presence of actual financial figures and the quarterly period covered indicate this is a quarterly financial report. The document length is 2098 characters, which is relatively short but contains substantive financial data, so it is not merely an announcement or certification. Therefore, the document is best classified as an Interim / Quarterly Report (IR). Q1 2023
2023-05-11 Chinese
112年第1季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple dates within a fiscal year, including assets, liabilities, and equity. The presence of quarterly dates (e.g., 112年03月31日, which corresponds to Q1) and detailed financial figures indicates this is a financial report for a period shorter than a full fiscal year. The document length is 3902 characters, which is relatively short but contains substantive financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2023
2023-05-11 Chinese
112年4月背書保證與資金貸與
Capital/Financing Update Classification · 95% confidence The document is a brief financial disclosure from a listed company, 景岳, reporting on the status of fund loans and endorsement guarantees for the current and previous month, with amounts all zero. It contains no detailed financial statements or analysis, no mention of a report being attached or published, and no regulatory certifications. The content is a straightforward update on financing-related data, specifically about loans and guarantees, which aligns with capital or financing updates. Given the short length and nature of the data, it is best classified as a Capital/Financing Update (CAP).
2023-05-10 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.